Identification of fibroblast growth factor receptor 2IIIB (FGFR2IIIB) as tumor suppressor in hepatocancerogenesis

被引：0
|
作者：
Amann, T.
Spruss, T.
Bataille, F.
Liedtke, C.
Milhlbauer, M.
Trautwein, C.
Bosserhoff, A. K.
Hellerbrand, C.
机构：
[1] Univ Regensburg, Dept Internal Med 1, D-8400 Regensburg, Germany
[2] Univ Regensburg, Inst Pharm, D-8400 Regensburg, Germany
[3] Univ Regensburg, Inst Pathol, D-8400 Regensburg, Germany
[4] Rhein Westfal TH Aachen, Dept Internal Med 3, D-5100 Aachen, Germany
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)61667-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
69
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] Fibroblast growth factor receptor 2-IIIb signaling is essential for embryonic submandibular salivary gland development
    Jaskoll, T
    Abichaker, G
    Sala, F
    Bellusci, S
    Melnick, M
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 453A - 453A
  • [32] The expression of keratinocyte growth factor receptor (FGFR2-IIIb) correlates with the high proliferative rate of HaCaT keratinocytes
    Nagy, Nikoletta
    Bata-Csoergo, Zsuzsanna
    Kopasz, Norbert
    Szeg, Csilla
    Pivarcsi, Andor
    Koreck, Andrea
    Dobozy, Attila
    Kemeny, Lajos
    Szell, Marta
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (08) : 596 - 605
  • [33] Cytokine regulation of fibroblast growth factor receptor 3 IIIb in intestinal epithelial cells
    Kanai, M
    Rosenberg, I
    Podolsky, DK
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 272 (04): : G885 - G893
  • [34] Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
    Masakazu Yashiro
    Kenji Kuroda
    Go Masuda
    Tomohisa Okuno
    Yuichiro Miki
    Yurie Yamamoto
    Tomohiro Sera
    Atsushi Sugimoto
    Shuhei Kushiyama
    Sadaaki Nishimura
    Shingo Togano
    Masaichi Ohira
    Scientific Reports, 11
  • [35] Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
    Yashiro, Masakazu
    Kuroda, Kenji
    Masuda, Go
    Okuno, Tomohisa
    Miki, Yuichiro
    Yamamoto, Yurie
    Sera, Tomohiro
    Sugimoto, Atsushi
    Kushiyama, Shuhei
    Nishimura, Sadaaki
    Togano, Shingo
    Ohira, Masaichi
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAs
    Jones, RB
    Wang, F
    Luo, YD
    Yu, CD
    Jin, CL
    Suzuki, T
    Kan, M
    McKeehan, WL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) : 4158 - 4167
  • [37] Keratinocyte growth factor binding to fibroblast growth factor receptor 2-IIIb promotes epithelial ovarian cancer cell proliferation and invasion
    Wu, Jun
    Han, Wei
    Yang, Weiwei
    Liu, Hongyu
    Li, Chunhong
    Guo, Ling
    Jin, Yan
    Zhang, Ruijie
    Chen, He
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S347 - S353
  • [38] Lack of discreet colocalization of epithelial apoptosis to the atretic precursor in the colon of the Fibroblast growth factor receptor 2IIIb mouse and staining consistent with cellular movement suggest a revised model of atresia formation
    Kowalkowski, Anna
    Zaremba, Krzysztof M.
    Rogers, Andrew P.
    Hoffman, Olivia R.
    Turco, Anne E.
    Nichol, Peter F.
    DEVELOPMENTAL DYNAMICS, 2020, 249 (06) : 741 - 753
  • [39] Determinants of specificity within fibroblast growth factor (FGF)-7 for the FGF receptor-2IIIB splice variant.
    Luo, Y
    Lu, W
    Kan, M
    McKeehan, WL
    FASEB JOURNAL, 1998, 12 (08): : A1301 - A1301
  • [40] Heparan sulfate is required for interaction and activation of the epithelial cell fibroblast growth factor receptor-2IIIb with stromal-derived fibroblast growth factor-7
    Jun-Hyeog Jang
    Fen Wang
    Mikio Kan
    In Vitro Cellular & Developmental Biology - Animal, 1997, 33 : 819 - 824
12345